Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00033254 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
A Phase 3 study of Tumors Metastatic to Brain, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 3
- Development phase
- 332
- Enrollment target
- 1
- Study location
NCT00033254: Completed Phase 3 study of Tumors Metastatic to Brain, sponsored by National Cancer Institute (NCI).
NCT00033254 is a Phase 3 study of Tumors Metastatic to Brain that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 332 participants, above the 32-participant average among 4 other Tumors Metastatic to Brain trials with a reported enrollment target (938% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00033254, a Phase 3 study of Tumors Metastatic to Brain, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 332 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized phase III trial to compare the effectiveness of radiation therapy with or without thalidomide in treating patients who have brain metastases. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as thalidomide may stop the growth of brain metastases by stopping blood flow to the tumor. It is not yet known whether radiation therapy is more effective with or without thalidomide in treating brain metastases.
Primary Outcome
The log-rank statistic will be used.
Conditions Studied
Interventions
- PROCEDURE quality-of-life assessment
- RADIATION radiation therapy
- DRUG thalidomide
Study Locations (1)
Pennsylvania
- Radiation Therapy Oncology Group - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2002-03 |
| Phase | Phase 3 |
What the finished NCT00033254 record still lists
NCT00033254 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, above the 32-participant average among 4 other Tumors Metastatic to Brain trials with a reported enrollment target (938% higher).
The record links to 1 condition, with Tumors Metastatic to Brain appearing as the primary indexed condition, and to 3 interventions - of which quality-of-life assessment is the first listed.
NCT00033254 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00033254 about?
NCT00033254 is a clinical study titled "Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases". Randomized phase III trial to compare the effectiveness of radiation therapy with or without thalidomide in treating patients who have brain metastases. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as thalidomide may stop the growth of brain metastases by stopping bloo...
What is the current status of trial NCT00033254?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 332 participants. The study started on 2002-03.
What conditions does trial NCT00033254 study?
This clinical trial studies the following conditions: Tumors Metastatic to Brain.
What interventions are being tested in trial NCT00033254?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), radiation therapy (RADIATION), thalidomide (DRUG).
Who is sponsoring clinical trial NCT00033254?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00033254 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tumors Metastatic to Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
RECRUITING · Phase 1
-
Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases
ACTIVE NOT RECRUITING · Phase 1
-
Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma
COMPLETED · Phase 2
-
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia